Core and Group Health

With drug shortages at an all-time high, the Senate Finance Committee wants to create a new program to incentivize improved contracting and purchasing practices in the supply chain by offering bonuses to hospitals and providers.

With concerns that costs could reach more than $1 billion over the next 6 years, North Carolina opted to stop coverage for the pricey new GLP-1s, saying the contracts between the drugmakers and the PBMs "are all-or-nothing."

Empyrean's EVOLVE 2024 brought together over 150 attendees to discuss ways that technology and communications can change how companies support and engage their workforce, create more connected cultures, and elevate benefits in the employee experience.

A private equity firm accused of trying to build a monopoly in radiology was dismissed as a defendant in an ongoing lawsuit filed by the Federal Trade Commission against U.S. Anesthesia Partners in Texas.

Senator Bernie Sanders is upping the pressure on Novo Nordisk to lower the cost of Wegovy in the U.S., although the Danish drugmaker asserts it charges lower prices in Europe because governments there can negotiate prices.

By employers implementing a multi-prong approach to weight health care, including offering weight management medication coverage, it will undoubtedly have positive business outcomes in the long-term.